LORI FRIEDMAN: Open Payments
NPI 1962633347 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 24 payments from 12 companies in 2025. Trend: 2023 $1,566 · 2024 $563 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $142 |
| Regeneron Healthcare Solutions, Inc. | 3 | $97 |
| GENZYME CORPORATION | 2 | $64 |
| Amgen Inc. | 2 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $51 |
| LEO Pharma Inc. | 2 | $46 |
| Incyte Corporation | 2 | $36 |
| Lilly USA, LLC | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $25 |
Products named: SKYRIZI, LIBTAYO, DUPIXENT, OTEZLA, ILUMYA, ADBRY, OPZELURA, TALTZ.
Industry payments across NY — which companies pay providers there.
